Abstract
Between January 1988 and May 1991 intravenous ganciclovir (GCV) treatment was administered to eight male AIDS-patients with unilateral cytomegalovirus(CMV)-retinitis. Despite of continuous therapy with at least the recommended dose of GCV, three patients developed slowly progressive CMV-retinitis in the fellow eye after 4 to 13 months. The progression could not be stopped by GCV and thus bilateral blindness resulted after 12 to 22 months. The number of CD4-lymphocytes in the blood was reduced in all patients, but particularly in patients with progressive disease. Treatment failure was partly related to the duration of CMV-retinitis and partly to the degree of immunodeficiency. Intravenous treatment with GCV alone can not stop the progression of CMV-retinitis in long-term survivors and in those with advanced immunodeficiency.
Similar content being viewed by others
References
Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome. Ophthalmology 1985; 92: 472–84.
Holland GN, Sidikaro Y, Kreiger AE et al. Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology 1987; 94: 815–23.
Palestine AG, Stevens G, Lane HC et al. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Am J Ophthalmol 1986; 101: 95–101.
Tynis AS, Taylor DL, Parkin PM. Cytomegalovirus and the acquired immunodeficiency syndrome. J Antimicrob Chemother 1989; 23 suppl A: 89–105.
Henderly DE, Freeman WR, Causey DM, Rao NA. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology 1987; 94: 425–34.
Fabricius EM, Holzer E, Prantl F. Erfahrungen mit DHPG (Ganciclovir) — Behandlung der Cytomegalievirus-Retinitis bei AIDS. Fortschr Ophthalmol 1989; 86: 124–8.
Gross JG, Bozzette SA, Mathews WR et al. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1990; 97: 681–6.
Bloom JN, Palestine AG. The diagnosis of cytomegalovirus retinitis. Ann Intern Med 1988; 109: 963–9.
Bernauer W, Daicker B. CMV-Retinitis bei AIDS — eine präfinale Komplikation? Klin MW Augenheilk 1991; 198: 447–50.
Erice A, Chou W, Biron KK et al. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. New Engl J Med 1989; 320: 289–93.
Schuman JS, Orellana J, Friedman AH, Teich S. Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol 1987; 31: 384–410.
Fabricius EM. Augenmanifestationen bei HIV-Infektionen. Stuttgart 1992, Ferdinand Enke Verlag.
Fenner TE, Garweg J, Hufert FT, Boehnke M, Schmitz H. Diagnosis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1-infected subjects by using the polymerase chain reaction. J Clin Microbiol 1991; 29: 2621–2622.
Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989; 107: 75–80.
Guyer DR, Jabs DA, Braut AM, Beschorner WE, Green WR. Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation. Arch Ophthalmol 1989; 107: 868–74.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bernauer, W., Meyer, P., Zimmerli, W. et al. Failure to control AIDS-related CMV-retinitis with intravenous ganciclovir. Int Ophthalmol 16, 453–457 (1992). https://doi.org/10.1007/BF00918436
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918436